0001567619-21-017578.txt : 20210924
0001567619-21-017578.hdr.sgml : 20210924
20210924173559
ACCESSION NUMBER: 0001567619-21-017578
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210922
FILED AS OF DATE: 20210924
DATE AS OF CHANGE: 20210924
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Newell Joe
CENTRAL INDEX KEY: 0001702457
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36548
FILM NUMBER: 211278402
MAIL ADDRESS:
STREET 1: C/O ATARA BIOTHERAPEUTICS, INC.
STREET 2: 611 GATEWAY BOULEVARD, SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001604464
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 460920988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-278-8930
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc1.xml
FORM 4
X0306
4
2021-09-22
0
0001604464
Atara Biotherapeutics, Inc.
ATRA
0001702457
Newell Joe
C/O ATARA BIOTHERAPEUTICS, INC.
611 GATEWAY BLVD., SUITE 900
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Operations Officer
Common Stock
2021-09-22
4
M
0
10500
12.15
A
130429
D
Common Stock
2021-09-22
4
S
0
10500
17
D
119929
D
Employee Stock Option (Right to Buy)
12.15
2021-09-22
4
M
0
8375
17.00
D
2030-02-28
Common Stock
8375
34875
D
Employee Stock Option (Right to Buy)
12.15
2021-09-22
4
M
0
2125
17.00
D
2030-02-28
Common Stock
2125
10625
D
Transaction pursuant to Rule 10b5-1 Plan adopted September 14, 2020.
1/48th of the shares subject to the stock option vest and become exercisable each month with the initial installment vesting on April 1, 2020, subject to the reporting person's continuous service.
/s/ David Tucker, Attorney-in-Fact for Joe Newell
2021-09-24